Trial Profile
Personalized therapy for pazopanib
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary)
- Indications Renal cell carcinoma; Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- 13 May 2016 New trial record